APA (7th ed.) Citation

Injinari, N., Asadollahi, S., Sefid, F., Arshadi, M., Hosseini, S. S., Ghoshouni, H., . . . Aghaeimeybodi, F. (2024, October). Impact of FCGR2A rs1801274 and IL-6R rs2228145 polymorphisms on tocilizumab response in the Iranian population with severe COVID-19. BMC Infectious Diseases.

Chicago Style (17th ed.) Citation

Injinari, Nastaran, et al. "Impact of FCGR2A Rs1801274 and IL-6R Rs2228145 Polymorphisms on Tocilizumab Response in the Iranian Population with Severe COVID-19." BMC Infectious Diseases Oct. 2024.

MLA (9th ed.) Citation

Injinari, Nastaran, et al. "Impact of FCGR2A Rs1801274 and IL-6R Rs2228145 Polymorphisms on Tocilizumab Response in the Iranian Population with Severe COVID-19." BMC Infectious Diseases, Oct. 2024.